Autopsy report · NCT03936751

Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY.

Cause of deathStaffing, sites or logistics, also drug or device supply Automatic label, confidence 0.5, unverified. How labels are made.

“COVID-19 pandemic and philips cpap machine recall”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years 9 months before it stopped.
150 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 4
Sponsor: University of Sao Paulo
Sponsor type: University, hospital or other
Conditions: Obstructive Sleep Apnea; Pulmonary Edema Cardiac Cause
Interventions: CPAP; Nasal Strips
Participants: 150
Sites: 4
Countries: Brazil

Trials that died the same way

Oritavancin for Staphylococcus Aureus Infections in Opioid Users
“COVID 19 pandemic” (57% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.